It will be very interesting to see how the wide use of these medications shape the food, alcohol, tobacco and cannabis industries (people are now only losing weight but losing their desire to consume these as well)
Reposted from
The Washington Post
The collective purchasing power of the roughly 16 million people taking GLP-1 weight-loss drugs such as Ozempic, Mounjaro and Wegovy has the potential to profoundly reshape the economy in the coming years.
Comments